FINASTERIDE Comprimé

Nazione: Canada

Lingua: francese

Fonte: Health Canada

Principio attivo:

Finastéride

Commercializzato da:

SIVEM PHARMACEUTICALS ULC

Codice ATC:

G04CB01

INN (Nome Internazionale):

FINASTERIDE

Dosaggio:

5MG

Forma farmaceutica:

Comprimé

Composizione:

Finastéride 5MG

Via di somministrazione:

Orale

Confezione:

30/100

Tipo di ricetta:

Prescription

Area terapeutica:

5 ALFA REDUCTASE INHIBITORS

Dettagli prodotto:

Numéro de groupe d'ingrédients actifs (GIA) :0124110001; AHFS:

Stato dell'autorizzazione:

APPROUVÉ

Data dell'autorizzazione:

2015-10-21

Scheda tecnica

RQR UDS L G
3URG L ),1
(,(
3D
VU
0212*5$3,(
( 3528,7
3U
),1$67(5,
(
&RPSULPpV GH ILQDVWpULGH %3
&RPSULPpVj
PJ
,Q LELHXU GH OD
α UpGXFDVH GH
SH ,,
1XPpURGHFRQU OHGHOD6RXPLVVLRQ
ZZZVLYHPFD
5 3
6DLQW/DXUHQW4XpEHF
UXH 'REULQ
6LHP 3URGXLV 3DUPDFHXLTXHV 8/
MXLQ
DHGH UpLVLRQ
RQR UDS L G
3URG L ),1
(,(
3D
VU
7DEOH GHV PDLqUHV
3$57,( ,
5(16(,*1(0(1763285 /(352)(66,211(/
(/$ 6$17e
5(16(,*1(0(1766200$,5(6 685 /(352'8,7
,1',&$7,216 (786$*(&/,1,48(
&2175( ,1',&$7,216
0,6(6 (1*$5'((7 35e&$87,216
())(76 ,1'e6,5$%/(6
,17(5$&7,216 0e',&$0(17(86(6
3262/2*,( (7 $'0,1,675$7,21
685'26$*(
02'( '$&7,21 (7 3$50$&2/2*,( &/,1,48(
67$%,/,7e (7 (175(326$*(
',5(&7,9(6 63e&,$/(6 '( 0$1,38/$7,21
)250(6 3262/2*,48(6 &20326,7,21 (7 &21',7,211(0(17
3$57,( ,,
5(16(,*1(0(1766,(17,),48(6
5(16(,*1(0(176 3
$50$&(87,48(6
e78'(6 &/,1,48(6
3$50$&2/2*,( 'e7$,//e(
72;,&2/2*,(
5e)e5(1&(6
3$57,( ,,, 5(16(,*1(0(1763285/(
216200$7(85
RQR UDS L G
3URG L ),1
(,(
3D
VU
3U
),1$67(5,
(
RPSULPpV GH ILQDVpULGH %3
RPSULPpV j
PJ
3$57,( ,
5(16(,*1(0(1763285 /(352)(66,211(/
(/$ 6$17e
5(16(,*1(0(1766200$,5(6 685/(3528,7
9RLH
GDGPLQLVUDLRQ
)RUPH SRVRORJLTXH
HQHXU
,QJUpGLHQ V QRQ PpGLFLQDX
2UDOH
&RPSULPp HQUREp SDU
ILOP j
PJ
/DFWRVHPRQRK GUDWp FHOOXORVH PLFURFULVWDOOLQH
$YLFHO3JO
FRODWHGDPLGRQVRGLTXH
3ULPRJHODPLGRQSUpJpODWLQLVp
$PLGRQ
GRFXVDWH VRGLTXHVWpDUDWH GHPDJQpVLXP
KGUR[ SURS OFHOOXORVHKSURPHOORVH
FS
GLR[GH GHWLWDQHWDOF )'&EOHX R[GH IHUULTXH
MDXQH
,1 ,
$7,216 (7 86$*(
/,1,48(
•
),1$67(5,'( FRPSULPpV GH ILQDVWpULGH %3 XQ LQKLELWHXU GH OD
α UpGXFWDVH GH W
SH
,,
HVW LQGLTXp HQ PRQRWKpUDSLH SRXU OH WUDLWHPHQW HW OD PDvWULVH GH OK
SHUWURSKLH
EpQLJQH GH OD SURVWDWH
%3 HW SRXU OD SUpYHQWLRQ GHV pYpQHPHQWV XURORJLTXHV HQ YXH
GH
UpGXLUH OH ULVTXH GH UpWHQWLRQ XULQDLUH DLJXs
UpGXLUH OH ULVTXH GDYRLU j VXELU XQH LQWHUYHQWLRQ FKLUXUJLFDOH
QRWDPPHQW
XQH
UpVHFWLRQ WUDQVXUpWUDOH GH OD SURVWDWH 5783 HW XQH SURVWDWHFWRPLH
•
),1$67(5,'( HQWUDvQH XQH UpJUHVVLRQGH OK SHUWURSKLH GH OD SURVWDWH
XQH DPpOLRUDWLRQ
GX GpELW XULQDLUH HW XQ VRXODJHPHQW GHV VPSWPHV UHOLpV j O
%3
•
),1$67(